86 related articles for article (PubMed ID: 1320294)
1. [Reduction of the proportion of anti-HCV-positive donations].
Quiles FJ; Sanz A; Cabanillas A; Sáenz P; Sánchez GM; Díaz F
Sangre (Barc); 1992 Apr; 37(2):153-4. PubMed ID: 1320294
[No Abstract] [Full Text] [Related]
2. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
3. [HCV antibodies in selected patient groups and blood donors].
Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
[TBL] [Abstract][Full Text] [Related]
4. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
[TBL] [Abstract][Full Text] [Related]
5. [The prevalence of antibodies to the hepatitis C virus (HCV) in patients with post-transfusional hepatitis and blood donors in Moldova].
Iancu L; Turcu T; Apetrei C; Porumb S; Dimitriu S; Donţu G; Mândru R; Moraru E; Duca M
Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):76-80. PubMed ID: 9132116
[No Abstract] [Full Text] [Related]
6. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
7. Prevention of posttransfusional non-A, non-B hepatitis by a screening test for hepatitis C virus antibody of donor bloods.
Ito S; Takaoka T; Kajimoto Y; Muguruma N; Fukuda T; Okabe T; Horikita M; Hibino S; Hayashi H; Honda H
Tokushima J Exp Med; 1991 Jun; 38(1-2):19-23. PubMed ID: 1719660
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
Kuperan P; Choon AT; Ding SH; Lee G
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis C virus infection among the plasmapheresis donors].
Wang S; Ding H; Zhang H
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):71-3. PubMed ID: 7522967
[TBL] [Abstract][Full Text] [Related]
11. [Different prevalence of hepatopathy among anti-HCV positive blood donors as a function of donation motive].
Suárez A; Sotorrío NG; Rodríguez M; Rodrigo L
Med Clin (Barc); 1993 May; 100(19):757. PubMed ID: 8391098
[No Abstract] [Full Text] [Related]
12. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of anti-HCV antibodies in France. Viral Hepatitis Study Group of the French Blood Transfusion Society.
Aguelles O; Janot C
Arch Virol Suppl; 1992; 4():249-52. PubMed ID: 1450696
[TBL] [Abstract][Full Text] [Related]
14. [Investigations on hepatitis C virus infection among heterosexuals with multiple partners and patients with sexually transmitted diseases].
Ding J
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):231-3. PubMed ID: 7511486
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV, anti-HCV, syphilis, HBsAg serologic tests among high-risk groups and blood donors in Yogyakarta, Indonesia.
Triwibowo
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():275-7. PubMed ID: 7886597
[TBL] [Abstract][Full Text] [Related]
16. [Investigation on anti-HCV antibody in Shashi District].
Wu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):331-3. PubMed ID: 7512448
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of screening and complementary tests for anti-HCV antibodies].
Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
[TBL] [Abstract][Full Text] [Related]
18. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
19. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C.
Alter MJ
Arch Pathol Lab Med; 1994 Apr; 118(4):342-5. PubMed ID: 7513149
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
Abb J
Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
